Healthcare & Medical Devices Global On demand · 24-48h

Global SUS (Single Use System) for Biopharma Process Market Strategic Research Report

Global SUS (Single Use System) for Biopharma Process Market …
$3,500 USD
Market Research Reports
Strategic Research Report
Global SUS (Single Use System) for Biopharma Process Market
$7.99B2025
18.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single-use Bioreactor, Disposable Sterile Bags, Disposable Filtration System, Other

By Application: Bio-pharmacy, CDMO, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: SATAKE MultiMix, Danaher, Thermo Fisher, Sartorius, Merck, Lepure China, JYSS Bio-Engineering, Tofflon, Duoning Biotechnology, ABEC, AUSTAR

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 105 pages
Market size 2025
$7.99B
Billion USD
Forecast CAGR
18.9%
2025-2032
Forecast 2032
$26.8B
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global SUS (Single Use System) for Biopharma Process market size is predicted to grow from US$ 7,991 million in 2025 to US$ 26,520 million in 2032; it is expected to grow at a CAGR of 18.9% from 2026 to 2032.

SUS (Single Use System) for Biopharma Process refers to biopharmaceutical manufacturing (bioprocessing) equipment designed to be used once (or for a single manufacturing campaign) and then discarded.

This report focuses on devices and consumables, mainly including single-use bioreactors, disposable sterile bags, and disposable filtration systems.

Global key players of SUS (single use system) for biopharma process include Danaher, Thermo Fisher, Sartorius, Merck, Lepure China, etc. The top five players hold a share about 73%. North America and Europe are the two largest markets, both has a share about 32%, followed by Asia-Pacific, with share 31%.

Market Challenges and Opportunities

Challenges

Raw material price fluctuations: Rising raw material prices may increase production costs and affect the competitiveness of the single-use systems (SUS) market for biopharmaceuticals.

Uncertainty of technological change: With the continuous development of technology, new substitutes or improved products may emerge, causing an impact on the market.

Environmental protection and sustainability requirements: With the increase in environmental awareness, higher requirements will be placed on the degradability and recycling rate of single-use systems (SUS) for biopharma process.

Opportunities

Emerging markets and developing countries: The demand for single-use systems (SUS) for biopharma process in these regions is increasing, providing a broad space for market growth.

Technological innovation: Through technological innovation and R&D investment, products with better performance and lower costs can be developed to enhance market competitiveness.

Establishment of industry standards: Actively promoting the establishment of industry standards will help regulate market order and improve product quality and safety.

This report presents a comprehensive overview of the global SUS (Single Use System) for Biopharma Process market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single-use Bioreactor
  • Disposable Sterile Bags
  • Disposable Filtration System
  • Other

Segment by players, this report covers

  • SATAKE MultiMix
  • Danaher
  • Thermo Fisher
  • Sartorius
  • Merck
  • Lepure China
  • JYSS Bio-Engineering
  • Tofflon
  • Duoning Biotechnology
  • ABEC
  • AUSTAR

Segment by Application

  • Bio-pharmacy
  • CDMO
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global SUS (Single Use System) for Biopharma Process market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Bio-pharmacy, CDMO, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global SUS (Single Use System) for Biopharma Process Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 18.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$7.99B
2025
Forecast
$26.8B
2032
CAGR
18.9%
2025–2032
Regionen
5
global
Key companies
SATAKE MultiMixDanaherThermo FisherSartoriusMerckLepure ChinaJYSS Bio-EngineeringTofflon
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single-use BioreactorDisposable Sterile BagsDisposable Filtration SystemOther
By Application
Bio-pharmacyCDMOOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single-use Bioreactor
  • 3.1.3 Disposable Sterile Bags
  • 3.1.4 Disposable Filtration System
  • 3.1.5 Other
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Bio-pharmacy
  • 4.1.3 CDMO
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 SATAKE MultiMix
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Danaher
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sartorius
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Merck
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Lepure China
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 JYSS Bio-Engineering
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tofflon
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Duoning Biotechnology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ABEC
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 AUSTAR
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global SUS (Single Use System) for Biopharma Process market size?
The global SUS (Single Use System) for Biopharma Process market is estimated at US$ 7.99 billion in 2025 (base year) and is projected to reach US$ 26.52 billion by 2032.
What growth rate is expected for the SUS (Single Use System) for Biopharma Process market through 2032?
The market is expected to grow at a CAGR of 18.9% from 2026 to 2032, expanding from US$ 7.99 billion in 2025 to US$ 26.52 billion in 2032, roughly 3.3 times its base-year value.
How is SUS (Single Use System) for Biopharma Process defined?
SUS (Single Use System) for Biopharma Process refers to biopharmaceutical manufacturing (bioprocessing) equipment designed to be used once (or for a single manufacturing campaign) and then discarded.
What are the main segments of the SUS (Single Use System) for Biopharma Process market by type?
By type, the market is segmented into Single-use Bioreactor, Disposable Sterile Bags, Disposable Filtration System and Other.
Which applications drive demand in the SUS (Single Use System) for Biopharma Process market?
Key applications covered include Bio-pharmacy, CDMO and Other.
Who are the key players in the SUS (Single Use System) for Biopharma Process market?
Key players profiled include SATAKE MultiMix, Danaher, Thermo Fisher, Sartorius, Merck, Lepure China, JYSS Bio-Engineering and Tofflon, among 11 companies covered in total.
Which regions and countries are covered for SUS (Single Use System) for Biopharma Process?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the SUS (Single Use System) for Biopharma Process market report?
The report is intended for manufacturers and solution providers, distributors and end users in Bio-pharmacy, CDMO and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the SUS (Single Use System) for Biopharma Process market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.